Abstract
Microorganisms are indispensable resources for the discovery of life-saving antibiotics, immunosuppressants, and antitumor drugs. Genome sequencing projects did not only confirm the metabolic prowess of bacteria and fungi for the production of such compounds, but they also unveiled a huge potential for the discovery of as yet untapped chemical diversity. In the past decade, various strategies have been explored to access the metabolites from orphan biosynthetic pathways, among which the empirical alteration of growth conditions is particularly appealing due to its simplicity and broad applicability. In order to avoid extensive and time-consuming screening programs, a miniaturization of this cultivation-based approach is highly desirable.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
